Bing Jiang Selected Research

Ischemia

4/2010	Inhibition of mitochondrial translocator protein prevents atrial fibrillation.
8/2008	Disruption of the complement cascade delays retinal ganglion cell death following retinal ischemia-reperfusion.
10/2005	[Effect of alpha-difluoromethylornithine on the expression of ODC mRNA in the cortex and hippocampus in rats after cerebral ischemia reperfusion].
8/2005	[Changes and significance of PAO activities and polyamine levels at different time of reperfusion after transient focal cerebral ischemia in rats].
10/2004	[Expression of ornithine decarboxylase mRNA in the cortex and hippocampus of rat after transient cerebral ischemia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bing Jiang Research Topics

Disease

30	Neoplasms (Cancer) 01/2022 - 03/2002
8	Inflammation (Inflammations) 07/2022 - 07/2013
6	Glaucoma 01/2021 - 06/2006
6	Glioma (Gliomas) 06/2016 - 11/2013
5	Breast Neoplasms (Breast Cancer) 01/2021 - 08/2007
5	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2013
5	Ischemia 04/2010 - 10/2004
4	Neuroinflammatory Diseases 01/2021 - 10/2010
4	Hepatocellular Carcinoma (Hepatoma) 03/2019 - 03/2002
4	Glioblastoma (Glioblastoma Multiforme) 06/2018 - 06/2015
3	Wounds and Injuries (Trauma) 02/2022 - 09/2015
3	Stomach Neoplasms (Stomach Cancer) 01/2022 - 01/2017
3	Rheumatoid Arthritis 01/2021 - 09/2019
3	Cerebral Hemorrhage 01/2021 - 11/2015
3	Hemorrhage 01/2017 - 01/2017
3	Optic Nerve Injuries 01/2013 - 05/2011
3	Hypoxia (Hypoxemia) 01/2011 - 09/2003
2	Myocardial Infarction 07/2022 - 09/2021
2	Retinal Neovascularization 01/2022 - 01/2021
2	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2021 - 01/2020
2	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 09/2019
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 09/2019
2	Open-Angle Glaucoma (Glaucoma, Open Angle) 01/2019 - 06/2006
2	Lymphatic Metastasis 01/2019 - 05/2017
2	Intervertebral Disc Displacement (Herniated Disc) 12/2018 - 11/2012
2	Ovarian Neoplasms (Ovarian Cancer) 05/2017 - 05/2016
2	Atrial Fibrillation 01/2017 - 04/2010
2	Hydrocephalus (Hydrocephaly) 01/2017 - 02/2016
2	Brain Injuries (Brain Injury) 01/2017 - 11/2016
2	Brain Edema (Cerebral Edema) 01/2017 - 02/2016
2	Disease Progression 01/2017 - 07/2015
2	Crush Injuries 07/2011 - 08/2003
2	Brain Ischemia (Cerebral Ischemia) 10/2005 - 08/2005
1	Triple Negative Breast Neoplasms 08/2022
1	Wound Infection (Wound Infections) 02/2022
1	Hyperthermia 02/2022
1	Bacterial Infections (Bacterial Infection) 02/2022
1	Cardiomegaly (Heart Hypertrophy) 09/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2021

Drug/Important Bio-Agent (IBA)

14	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
8	Retinaldehyde (Retinal)IBA 05/2021 - 08/2008
8	Messenger RNA (mRNA)IBA 05/2017 - 09/2003
6	Therapeutic UsesIBA 07/2022 - 07/2011
6	CytokinesIBA 07/2021 - 07/2011
5	Long Noncoding RNAIBA 08/2022 - 03/2016
5	Oxygen (Dioxygen)IBA 01/2022 - 11/2015
5	Pharmaceutical PreparationsIBA 01/2022 - 11/2008
5	Ferritins (Ferritin)IBA 01/2022 - 12/2018
4	MicroRNAs (MicroRNA)IBA 02/2016 - 01/2013
3	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 04/2015
3	CarbonIBA 01/2021 - 12/2018
3	Biological ProductsIBA 01/2021 - 07/2015
3	salicylhydroxamic acid (SHAM)IBA 01/2020 - 07/2011
3	Fatty Acid Synthases (Fatty Acid Synthase)IBA 01/2019 - 02/2016
3	CateninsIBA 01/2019 - 01/2012
3	Temozolomide (Temodar)FDA LinkGeneric 06/2018 - 06/2016
3	1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA 01/2017 - 01/2017
3	Transcription Factors (Transcription Factor)IBA 09/2015 - 09/2003
2	TabletsIBA 07/2022 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2022 - 01/2019
2	Adenosine Triphosphate (ATP)IBA 05/2021 - 04/2010
2	AutoantibodiesIBA 01/2021 - 12/2019
2	EnzymesIBA 01/2021 - 03/2019
2	Peroxidase (Myeloperoxidase)IBA 01/2021 - 03/2019
2	Glyburide (Glibenclamide)FDA LinkGeneric 01/2021 - 01/2017
2	Glutamic Acid (Glutamate)FDA Link 01/2021 - 01/2019
2	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2019
2	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2020 - 01/2017
2	CurcuminIBA 01/2019 - 05/2016
2	Cyclin D1IBA 05/2017 - 06/2016
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2017 - 02/2016
2	LigandsIBA 01/2017 - 07/2009
2	Neuroprotective AgentsIBA 01/2017 - 08/2003
2	Small Interfering RNA (siRNA)IBA 11/2013 - 08/2007
2	DNA (Deoxyribonucleic Acid)IBA 09/2003 - 03/2002
2	C 1027IBA 04/2002 - 03/2002
1	Neurotransmitter Agents (Neurotransmitter)IBA 07/2022
1	HydrogelsIBA 02/2022
1	MXeneIBA 02/2022
1	ApoferritinsIBA 01/2022
1	Drug CarriersIBA 01/2022
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2022
1	Adrenergic Agents (Adrenergic Drugs)IBA 09/2021
1	Colchicine FDA LinkGeneric 09/2021
1	Interferon-gamma (Interferon, gamma)IBA 07/2021
1	InterferonsIBA 07/2021
1	LipopolysaccharidesIBA 05/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 02/2021
1	Circular RNAIBA 02/2021
1	Aspartic Acid (Aspartate)FDA Link 01/2021
1	Hydroxyl RadicalIBA 01/2021

Therapy/Procedure

11	Therapeutics 01/2022 - 11/2008
2	Photothermal Therapy 02/2022 - 07/2020
2	Intravitreal Injections 01/2022 - 01/2019
2	Precision Medicine 01/2022 - 03/2019
2	Drug Therapy (Chemotherapy) 01/2021 - 07/2015
2	Chemoprevention 01/2019 - 05/2016
2	Transplantation 01/2013 - 07/2011
1	Intravenous Injections 01/2022
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2021